{"hands_on_practices": [{"introduction": "The first step toward a successful sialendoscopy is selecting the right tools, a decision grounded in the patient's specific anatomy. This exercise demonstrates how to apply fundamental geometric principles to determine the maximum safe diameter of an introducer sheath for a given salivary duct. By modeling the relationship between the instrument and the duct wall, you will learn to quantify the trade-off between maximizing the working channel and ensuring adequate space for irrigation, a key factor in procedural success and safety [@problem_id:4768957].", "problem": "A clinician planning sialendoscopy must select an introducer sheath that balances luminal preservation for irrigation with minimizing circumferential stretch of the duct wall. Model each salivary duct as a circular cylinder with native intraluminal diameter equal to $1.5\\,\\text{mm}$ for Stensen’s duct and $2.0\\,\\text{mm}$ for Wharton’s duct. The introducer sheath is modeled as a circular cylinder inserted coaxially; assume the duct retains a circular cross-section without eccentric deformation and that the sheath does not compress the duct wall into an oval shape.\n\nStarting from the definition of the area of a circle, first compute the ratio of the native cross-sectional areas of Stensen’s duct to Wharton’s duct. Next, impose the following safety and performance constraint grounded in laminar flow considerations: to maintain adequate irrigation flow and mucosal perfusion during sheath placement, the residual patent cross-sectional area (the annular area between the duct wall and the sheath outer surface) must be at least a fraction $f$ of the native duct area, with $f = 0.30$. Under this constraint, derive from first principles the expression for the maximum permissible outer diameter $D_{\\text{max}}(d,f)$ of the sheath as a function of the native duct diameter $d$ and the fraction $f$, and then evaluate $D_{\\text{max}}$ for Stensen’s and Wharton’s ducts.\n\nRound all numerical answers to four significant figures. Express diameters in millimeters (mm). The final answer must consist of three entries presented in the following order: the area ratio (dimensionless), the maximum sheath outer diameter for Stensen’s duct (mm), and the maximum sheath outer diameter for Wharton’s duct (mm).", "solution": "The problem is assessed to be valid as it is scientifically grounded, well-posed, objective, self-contained, and logically consistent. The model, while an idealization, is a standard approach in biomedical engineering. We proceed with the solution.\n\nThe problem requires a three-part calculation based on a geometric model of salivary ducts and an introducer sheath. The ducts and sheath are modeled as coaxial circular cylinders.\n\nFirst, we address the ratio of the native cross-sectional areas of Stensen’s duct to Wharton’s duct. Let $d$ represent the diameter of a circular cross-section. The radius $r$ is half the diameter, $r = \\frac{d}{2}$. The area $A$ of the circle is given by the formula $A = \\pi r^2$. Substituting the expression for the radius in terms of the diameter, we have:\n$$A = \\pi \\left(\\frac{d}{2}\\right)^2 = \\frac{\\pi d^2}{4}$$\n\nLet $d_S$ and $d_W$ be the native intraluminal diameters of Stensen’s duct and Wharton’s duct, respectively. The provided values are $d_S = 1.5\\,\\text{mm}$ and $d_W = 2.0\\,\\text{mm}$.\nThe corresponding native cross-sectional areas are:\n$$A_S = \\frac{\\pi d_S^2}{4}$$\n$$A_W = \\frac{\\pi d_W^2}{4}$$\n\nThe ratio of these areas, $\\frac{A_S}{A_W}$, is:\n$$\\frac{A_S}{A_W} = \\frac{\\frac{\\pi d_S^2}{4}}{\\frac{\\pi d_W^2}{4}} = \\frac{d_S^2}{d_W^2} = \\left(\\frac{d_S}{d_W}\\right)^2$$\nSubstituting the numerical values:\n$$\\frac{A_S}{A_W} = \\left(\\frac{1.5}{2.0}\\right)^2 = (0.75)^2 = 0.5625$$\nThis value is exact and has four significant figures, so no further rounding is needed.\n\nNext, we derive the expression for the maximum permissible outer diameter $D_{\\text{max}}$ of the sheath as a function of the native duct diameter $d$ and the fraction $f$.\nLet $d$ be the native diameter of a generic duct, and let its native area be $A_{\\text{native}} = \\frac{\\pi d^2}{4}$.\nLet $D$ be the outer diameter of the coaxially inserted sheath. The area occupied by the sheath is $A_{\\text{sheath}} = \\frac{\\pi D^2}{4}$.\nThe residual patent cross-sectional area, $A_{\\text{residual}}$, is the annular area, which is the difference between the native duct area and the sheath area:\n$$A_{\\text{residual}} = A_{\\text{native}} - A_{\\text{sheath}} = \\frac{\\pi d^2}{4} - \\frac{\\pi D^2}{4} = \\frac{\\pi}{4}(d^2 - D^2)$$\n\nThe problem states a constraint that this residual area must be at least a fraction $f$ of the native duct area:\n$$A_{\\text{residual}} \\ge f \\cdot A_{\\text{native}}$$\nSubstituting the area expressions into the inequality:\n$$\\frac{\\pi}{4}(d^2 - D^2) \\ge f \\left(\\frac{\\pi d^2}{4}\\right)$$\nThe term $\\frac{\\pi}{4}$ is a positive constant and can be canceled from both sides:\n$$d^2 - D^2 \\ge f d^2$$\nWe are seeking the maximum permissible outer diameter of the sheath, denoted $D_{\\text{max}}$. This maximum diameter corresponds to the minimum allowed residual area, which occurs when the inequality becomes an equality. Let $D = D_{\\text{max}}$:\n$$d^2 - D_{\\text{max}}^2 = f d^2$$\nTo solve for $D_{\\text{max}}$, we rearrange the equation:\n$$D_{\\text{max}}^2 = d^2 - f d^2 = d^2(1 - f)$$\nTaking the square root of both sides (and noting that diameter must be a positive quantity), we obtain the derived expression:\n$$D_{\\text{max}}(d, f) = \\sqrt{d^2(1 - f)} = d\\sqrt{1-f}$$\n\nFinally, we evaluate $D_{\\text{max}}$ for both Stensen’s and Wharton’s ducts using the given value $f = 0.30$.\nThe factor $\\sqrt{1-f}$ is $\\sqrt{1 - 0.30} = \\sqrt{0.70}$.\n\nFor Stensen’s duct, $d_S = 1.5\\,\\text{mm}$:\n$$D_{\\text{max},S} = d_S \\sqrt{1-f} = 1.5 \\sqrt{0.70} \\approx 1.5 \\times 0.8366600265... \\approx 1.2549900398...$$\nRounding to four significant figures, the maximum sheath diameter for Stensen's duct is $1.255\\,\\text{mm}$.\n\nFor Wharton’s duct, $d_W = 2.0\\,\\text{mm}$:\n$$D_{\\text{max},W} = d_W \\sqrt{1-f} = 2.0 \\sqrt{0.70} \\approx 2.0 \\times 0.8366600265... \\approx 1.673320053...$$\nRounding to four significant figures, the maximum sheath diameter for Wharton's duct is $1.673\\,\\text{mm}$.\n\nThe three required results are the area ratio ($0.5625$), the maximum sheath diameter for Stensen's duct ($1.255\\,\\text{mm}$), and the maximum sheath diameter for Wharton's duct ($1.673\\,\\text{mm}$).", "answer": "$$\\boxed{\\begin{pmatrix} 0.5625  1.255  1.673 \\end{pmatrix}}$$", "id": "4768957"}, {"introduction": "Navigating the complex, branching anatomy of the salivary glands requires more than just good hand-eye coordination; it demands sound clinical judgment grounded in physical principles. This problem presents a common intraoperative decision at a ductal bifurcation, challenging you to apply your understanding of fluid dynamics and mechanical forces to choose the safest and most diagnostically effective path. This practice hones the qualitative reasoning skills essential for minimizing iatrogenic trauma and maximizing the success of the endoscopic exploration [@problem_id:4768924].", "problem": "A clinician is performing diagnostic and interventional sialendoscopy in a patient with recurrent postprandial swelling of the parotid gland suggestive of chronic obstructive sialadenitis. The endoscope approaches a bifurcation at the parotid hilum. The endoscopic image and calibrated scale indicate the following geometry: the superior branch arises at a shallow angle relative to the parent duct, and has an apparent luminal radius of approximately $0.5\\,\\text{mm}$; the inferior branch aligns closely with the main axis of Stensen’s duct and has an apparent luminal radius of approximately $0.8\\,\\text{mm}$. The initial straight segments of both branches before further arborization are each approximately $8\\,\\text{mm}$ in length. The operator is using a small-caliber endoscope with an outer diameter of $0.8\\,\\text{mm}$ and intends to irrigate with low flow to avoid mural trauma. Saliva is modeled as a Newtonian fluid with dynamic viscosity approximately $1.0\\times 10^{-3}\\,\\text{Pa}\\cdot\\text{s}$ and ductal flow is assumed laminar under gentle irrigation.\n\nStarting from fundamental fluid-mechanical and tissue-safety principles that relate flow resistance, shear stress, and geometric alignment to the risk of ductal epithelial injury and to the likelihood of successful diagnostic mapping of obstructions, determine which branch should be explored first to maximize diagnostic yield while minimizing trauma. Choose the single best option.\n\nA. Advance first into the inferior, larger-caliber branch that continues the main duct axis, using low-pressure irrigation to map resistance and postponing entry into the superior branch until after confirming patency and performing atraumatic dilation if needed.\n\nB. Advance directly into the superior, narrower branch first to target the likely obstructed segment before it collapses from irrigation and to prevent debris migration.\n\nC. Place a guidewire into each branch simultaneously and then track the endoscope along the superior branch, because dual guidance reduces wall contact forces.\n\nD. Avoid entering either branch initially and instead increase irrigation pressure to force-open the superior branch, then select the branch based on the observed flow distribution.\n\nE. Pre-dilate the papilla and immediately pass a larger-caliber endoscope into the superior branch to ensure detection of small stones before edema develops.", "solution": "The problem statement is first subjected to validation to ensure it is scientifically sound, well-posed, and complete.\n\n### Step 1: Extract Givens\n- **Procedure:** Diagnostic and interventional sialendoscopy.\n- **Clinical Indication:** Recurrent postprandial swelling of the parotid gland, suggestive of chronic obstructive sialadenitis.\n- **Anatomy at Bifurcation:**\n    - **Superior Branch:**\n        - Arises at a shallow angle to the parent duct.\n        - Luminal radius, $r_s \\approx 0.5\\,\\text{mm}$.\n        - Initial straight segment length, $L_s \\approx 8\\,\\text{mm}$.\n    - **Inferior Branch:**\n        - Aligns closely with the main axis of Stensen’s duct.\n        - Luminal radius, $r_i \\approx 0.8\\,\\text{mm}$.\n        - Initial straight segment length, $L_i \\approx 8\\,\\text{mm}$.\n- **Instrumentation  Technique:**\n    - Endoscope outer diameter, $d_{\\text{scope}} = 0.8\\,\\text{mm}$, which implies an endoscope radius of $r_{\\text{scope}} = 0.4\\,\\text{mm}$.\n    - Irrigation is performed at a low flow rate.\n- **Fluid  Flow Model:**\n    - Saliva is modeled as a Newtonian fluid.\n    - Dynamic viscosity, $\\mu \\approx 1.0\\times 10^{-3}\\,\\text{Pa}\\cdot\\text{s}$.\n    - Flow is assumed to be laminar.\n- **Objective:** Determine the optimal branch to explore first to maximize diagnostic yield while minimizing trauma, based on fluid mechanics and tissue safety principles.\n\n### Step 2: Validate Using Extracted Givens\n1.  **Scientific Groundedness:** The problem is grounded in the established medical procedure of sialendoscopy and applies fundamental principles of fluid mechanics (laminar flow, hydraulic resistance, shear stress) to a biological system. The physical parameters provided—duct radii, endoscope diameter, fluid viscosity (similar to water)—are realistic for this clinical context. The simplification of saliva as a Newtonian fluid is a common and acceptable approximation for such analyses, especially at low shear rates.\n2.  **Well-Posedness:** The problem is well-posed. It provides sufficient geometric, material, and procedural constraints to allow for a reasoned, qualitative decision based on the stated objective of minimizing trauma and maximizing diagnostic success. A unique optimal strategy can be deduced from these principles.\n3.  **Objectivity:** The problem is stated in objective, clinical, and technical terms, free from subjective or ambiguous language.\n4.  **Completeness and Consistency:** The provided data are internally consistent and sufficient. For instance, the endoscope radius ($r_{\\text{scope}} = 0.4\\,\\text{mm}$) is smaller than both the superior branch radius ($r_s = 0.5\\,\\text{mm}$) and the inferior branch radius ($r_i = 0.8\\,\\text{mm}$), confirming that insertion into either branch is geometrically possible, albeit with different levels of clearance.\n\n### Step 3: Verdict and Action\nThe problem statement is **valid**. It presents a realistic clinical scenario that can be analyzed using fundamental scientific and engineering principles. The solution process can now proceed.\n\n### Derivation of Optimal Strategy\n\nThe decision of which ductal branch to enter first must balance the probability of a successful diagnosis against the risk of iatrogenic trauma. The primary risks are mechanical injury from the endoscope itself and hydrodynamic injury from the irrigation fluid.\n\n**1. Analysis of Mechanical Trauma Risk:**\n\nThe risk of mechanical trauma (e.g., mucosal abrasion, perforation) is related to the forces exerted by the endoscope on the duct wall. Two factors are key: ductal alignment and the clearance between the endoscope and the duct wall.\n\n- **Alignment:** The inferior branch \"aligns closely with the main axis of Stensen’s duct.\" This represents a natural continuation of the endoscope's trajectory, requiring minimal bending and lateral force to enter. Conversely, the superior branch arises at a \"shallow angle,\" meaning the endoscope must be deflected to enter it. This deflection will concentrate force on the carina (the tissue at the bifurcation) and the outer wall of the superior branch's origin, significantly increasing the risk of mechanical injury.\n\n- **Clearance:** The radial clearance is the difference between the duct radius and the endoscope radius ($r_{\\text{duct}} - r_{\\text{scope}}$).\n    - **Inferior Branch:** Clearance = $r_i - r_{\\text{scope}} = 0.8\\,\\text{mm} - 0.4\\,\\text{mm} = 0.4\\,\\text{mm}$.\n    - **Superior Branch:** Clearance = $r_s - r_{\\text{scope}} = 0.5\\,\\text{mm} - 0.4\\,\\text{mm} = 0.1\\,\\text{mm}$.\nThe clearance in the superior branch is only $25\\%$ of the clearance in the inferior branch. This extremely tight fit greatly increases the likelihood of friction, wall contact, and mucosal stripping during advancement.\n\nBased on both alignment and clearance, the mechanical risk associated with entering the superior branch is substantially higher than that for the inferior branch.\n\n**2. Analysis of Hydrodynamic Trauma Risk:**\n\nThe problem specifies low-flow irrigation. The pressure required to maintain a given flow rate ($Q$) and the resulting wall shear stress ($\\tau_w$) are the main determinants of hydrodynamic trauma (barotrauma and epithelial desquamation).\n\n- **Hydraulic Resistance:** For laminar flow in the annular space between the endoscope and the duct wall, the hydraulic resistance ($R_h$) determines the pressure gradient ($\\Delta P$) needed for a given flow rate ($Q$), where $\\Delta P = Q \\cdot R_h$. While the exact formula for an annulus is complex, resistance is strongly and inversely related to the dimensions of the flow channel. A key factor is the cross-sectional area of the annulus, $A = \\pi (r_{\\text{duct}}^2 - r_{\\text{scope}}^2)$.\n    - **Inferior Branch:** $A_i = \\pi ( (0.8\\,\\text{mm})^2 - (0.4\\,\\text{mm})^2 ) = \\pi(0.64 - 0.16)\\,\\text{mm}^2 = 0.48\\pi\\,\\text{mm}^2$.\n    - **Superior Branch:** $A_s = \\pi( (0.5\\,\\text{mm})^2 - (0.4\\,\\text{mm})^2 ) = \\pi(0.25 - 0.16)\\,\\text{mm}^2 = 0.09\\pi\\,\\text{mm}^2$.\nThe flow area in the superior branch is less than one-fifth of that in the inferior branch ($0.09 / 0.48 \\approx 0.1875$). Consequently, the hydraulic resistance in the superior branch will be significantly higher. Achieving the same \"low flow\" rate would require a much higher irrigation pressure, increasing the risk of barotrauma.\n\n- **Wall Shear Stress ($\\tau_w$):** Shear stress at the duct wall is proportional to the viscosity and the velocity gradient at the wall. For a given flow rate $Q$, the average fluid velocity $v_{\\text{avg}} = Q/A$ will be much higher in the superior branch due to its smaller area $A_s$. This higher velocity, combined with the very narrow clearance ($0.1\\,\\text{mm}$), will produce a much steeper velocity gradient and therefore a significantly higher wall shear stress, increasing the risk of damaging the delicate ductal epithelium.\n\n**3. Diagnostic Strategy:**\n\nA fundamental principle of endoscopy and interventional procedures is to proceed from low-risk to high-risk maneuvers.\n- **Exploring the Inferior Branch First:** This is the low-risk option. It is mechanically and hydrodynamically safer. This allows the clinician to map the main, larger-caliber ductal system. If an obstruction is found and treated here, the procedure might be complete. If this branch is patent, it provides valuable diagnostic information and rules out obstruction in a significant portion of the gland, all while preserving the integrity of the ductal system for a potential subsequent, higher-risk exploration of the superior branch.\n- **Exploring the Superior Branch First:** This is a high-risk, high-commitment opening move. A complication here (e.g., perforation, bleeding, or edema from trauma) could obscure visibility and force the termination of the entire procedure, resulting in a complete diagnostic failure and potential harm to the patient.\n\n**Conclusion:** The optimal strategy is to first enter the inferior branch, which is wider, axially aligned, and presents lower mechanical and hydrodynamic risks. This approach maximizes the potential for a safe and successful diagnosis by following a logical, staged progression.\n\n### Evaluation of Options\n\n**A. Advance first into the inferior, larger-caliber branch that continues the main duct axis, using low-pressure irrigation to map resistance and postponing entry into the superior branch until after confirming patency and performing atraumatic dilation if needed.**\nThis option perfectly matches the derived optimal strategy. It prioritizes safety by choosing the path of least mechanical and hydrodynamic resistance first. It adopts a sound, staged diagnostic approach, preserving options for later intervention.\n**Verdict: Correct.**\n\n**B. Advance directly into the superior, narrower branch first to target the likely obstructed segment before it collapses from irrigation and to prevent debris migration.**\nThis strategy is high-risk due to the angulation and tight clearance, as analyzed above. The rationale provided is flawed: irrigation causes distension, not collapse. Entering an obstructed duct first is a primary mechanism for dislodging debris, not preventing its migration.\n**Verdict: Incorrect.**\n\n**C. Place a guidewire into each branch simultaneously and then track the endoscope along the superior branch, because dual guidance reduces wall contact forces.**\nThis describes a technically complex and non-standard maneuver. Prioritizing the high-risk superior branch remains a poor choice. The claim that dual guidance reduces contact forces in this specific scenario is unsubstantiated and questionable; the governing factor is the stiffness of the scope against the duct's angle.\n**Verdict: Incorrect.**\n\n**D. Avoid entering either branch initially and instead increase irrigation pressure to force-open the superior branch, then select the branch based on the observed flow distribution.**\nUsing high pressure to \"force-open\" a duct is a dangerous maneuver that directly contradicts the principle of minimizing trauma. It risks acute barotrauma, pain, and extravasation of fluid into the gland parenchyma.\n**Verdict: Incorrect.**\n\n**E. Pre-dilate the papilla and immediately pass a larger-caliber endoscope into the superior branch to ensure detection of small stones before edema develops.**\nPapillary dilation does not alter the downstream bifurcation geometry. Attempting to pass a *larger* endoscope is physically impossible and nonsensical given the duct's dimensions ($1.0\\,\\text{mm}$ diameter duct vs. a scope with $>0.8\\,\\text{mm}$ diameter). This approach would guarantee trauma and cause the very edema it claims to avoid.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "4768924"}, {"introduction": "Ensuring patient safety during a prolonged sialendoscopy extends beyond mechanical technique to include vigilant pharmacological management. This problem tackles the crucial issue of preventing Local Anesthetic Systemic Toxicity (LAST) by using pharmacokinetic principles to model drug accumulation and elimination over time. By calculating the maximum safe dosage for repeated administrations of lidocaine, you will practice the quantitative skills needed to maintain a therapeutic effect while staying safely below the systemic toxicity threshold [@problem_id:4768902].", "problem": "A patient undergoing interventional sialendoscopy for obstructive salivary gland disease requires both topical mucosal anesthesia and local infiltration anesthesia. To minimize the risk of Local Anesthetic Systemic Toxicity (LAST), your institutional policy caps the systemic-equivalent lidocaine exposure at a maximum of $4$ mg/kg at any time. Consider a single-compartment first-order elimination model with instantaneous absorption of the bioavailable fraction of each administered dose, and elimination characterized by a half-life $t_{1/2}$.\n\nAssume the following scientifically standard and foundational principles:\n- The maximum systemic-equivalent instantaneous burden $M_{\\max}$ is computed from the weight-based cap: $M_{\\max} = (\\text{dose limit in mg/kg}) \\times (\\text{body weight in kg})$.\n- First-order elimination implies that the time course of the systemic-equivalent amount $A(t)$ (in mg) from a dose $D_i$ (in mg) given at time $t_i$, with immediate bioavailable fraction $f_i$, is $f_i D_i \\exp\\!\\big(-k(t - t_i)\\big)$ for $t \\ge t_i$, where $k = \\ln(2)/t_{1/2}$.\n- Superposition applies: the total $A(t)$ is the sum of contributions from all prior doses.\n\nA $70$ kg adult without vasoconstrictor exposure is scheduled for a prolonged sialendoscopy lasting $90$ minutes. The anesthetic plan is:\n- Topical oropharyngeal lidocaine spray: each actuation delivers $10$ mg lidocaine base. At $t = 0$ minutes, $3$ actuations are applied; at $t = 60$ minutes, $2$ actuations are applied. The immediate systemic bioavailability fraction from mucosal spray is $f_{\\mathrm{spray}} = 0.30$.\n- Local infiltration at the duct papilla and floor of mouth: two equal infiltration doses of lidocaine base are planned at $t = 15$ minutes and $t = 75$ minutes. Assume immediate systemic bioavailability fraction $f_{\\mathrm{inf}} = 1.00$ for infiltration.\n- Use a lidocaine elimination half-life of $t_{1/2} = 100$ minutes.\n- Assume no epinephrine is used and ignore distributional delays; treat absorption as immediate for the stated fractions.\n\nUsing only the above fundamentals and assumptions, determine the maximum allowable per-injection infiltration dose $y$ (in mg) such that the total systemic-equivalent instantaneous burden $A(t)$ never exceeds the cap derived from the $4$ mg/kg limit for this $70$ kg patient at any time during the plan. Express your final result as a single number in mg, rounded to three significant figures. Use radians for any angles if they were to arise, though none are expected here, and express the final numeric answer in mg as instructed.", "solution": "The problem requires determining the maximum allowable per-injection infiltration dose, denoted by a variable $y$ in milligrams, such that the total systemic-equivalent instantaneous burden of lidocaine, $A(t)$, does not exceed a specified toxicity threshold at any time. The solution involves constructing a model for $A(t)$ based on the principles of first-order pharmacokinetics and then finding the value of $y$ that satisfies the constraint.\n\nFirst, the givens of the problem are established.\nThe patient's body weight is $W = 70\\,\\text{kg}$.\nThe institutional policy caps the systemic-equivalent lidocaine exposure at $4$ mg/kg. Therefore, the maximum systemic-equivalent instantaneous burden, $M_{\\max}$, is:\n$$M_{\\max} = (4 \\, \\text{mg/kg}) \\times (70 \\, \\text{kg}) = 280 \\, \\text{mg}$$\nThe elimination half-life of lidocaine is given as $t_{1/2} = 100\\,\\text{minutes}$.\nThe elimination rate constant, $k$, for a first-order process is related to the half-life by:\n$$k = \\frac{\\ln(2)}{t_{1/2}} = \\frac{\\ln(2)}{100} \\, \\text{min}^{-1}$$\n\nThe total systemic-equivalent amount of lidocaine at time $t$, $A(t)$, is the sum of the contributions from all doses administered up to that time. The contribution from a single dose $D_i$ with immediate bioavailability fraction $f_i$ administered at time $t_i$ is given by $f_i D_i \\exp(-k(t - t_i))$ for $t \\ge t_i$.\n\nThe anesthetic plan consists of four distinct administrations:\n1.  Dose $D_1$ at $t_1 = 0$ min: Topical spray.\n    Dose is $D_1 = 3 \\text{ actuations} \\times 10 \\, \\text{mg/actuation} = 30$ mg.\n    Bioavailability is $f_{\\mathrm{spray}} = 0.30$.\n    The bioavailable dose that enters systemic circulation is $A_{0,1} = f_{\\mathrm{spray}} D_1 = 0.30 \\times 30 = 9$ mg.\n\n2.  Dose $D_2$ at $t_2 = 15$ min: Local infiltration.\n    Dose is $D_2 = y$ mg.\n    Bioavailability is $f_{\\mathrm{inf}} = 1.00$.\n    The bioavailable dose is $A_{0,2} = f_{\\mathrm{inf}} D_2 = 1.00 \\times y = y$.\n\n3.  Dose $D_3$ at $t_3 = 60$ min: Topical spray.\n    Dose is $D_3 = 2 \\text{ actuations} \\times 10 \\, \\text{mg/actuation} = 20$ mg.\n    Bioavailability is $f_{\\mathrm{spray}} = 0.30$.\n    The bioavailable dose is $A_{0,3} = f_{\\mathrm{spray}} D_3 = 0.30 \\times 20 = 6$ mg.\n\n4.  Dose $D_4$ at $t_4 = 75$ min: Local infiltration.\n    Dose is $D_4 = y$ mg.\n    Bioavailability is $f_{\\mathrm{inf}} = 1.00$.\n    The bioavailable dose is $A_{0,4} = f_{\\mathrm{inf}} D_4 = 1.00 \\times y = y$.\n\nUsing the principle of superposition, the total systemic burden $A(t)$ is a piecewise function:\nFor $0 \\le t  15$:\n$$A(t) = A_{0,1} \\exp(-k(t - t_1)) = 9 \\exp(-kt)$$\nFor $15 \\le t  60$:\n$$A(t) = 9 \\exp(-kt) + A_{0,2} \\exp(-k(t - t_2)) = 9 \\exp(-kt) + y \\exp(-k(t - 15))$$\nFor $60 \\le t  75$:\n$$A(t) = 9 \\exp(-kt) + y \\exp(-k(t - 15)) + A_{0,3} \\exp(-k(t - t_3)) = 9 \\exp(-kt) + y \\exp(-k(t - 15)) + 6 \\exp(-k(t - 60))$$\nFor $t \\ge 75$:\n$$A(t) = 9 \\exp(-kt) + y \\exp(-k(t - 15)) + 6 \\exp(-k(t - 60)) + A_{0,4} \\exp(-k(t - t_4))$$\n$$A(t) = 9 \\exp(-kt) + y \\exp(-k(t - 15)) + 6 \\exp(-k(t - 60)) + y \\exp(-k(t - 75))$$\n\nThe function $A(t)$ consists of a sum of decaying exponential terms. Within any interval between doses, the function is strictly decreasing because its derivative, $\\frac{dA}{dt} = -k \\sum A_{0,i} \\exp(-k(t-t_i))$, is always negative. Due to the assumption of instantaneous absorption, the function exhibits upward jumps at each administration time $t_i$. Consequently, the maximum value of $A(t)$ over its entire domain must occur immediately following one of the dose administrations. We must therefore evaluate $A(t)$ at $t \\to t_i^+$ for $i \\in \\{1, 2, 3, 4\\}$ and ensure that each of these peak values is less than or equal to $M_{\\max} = 280$ mg.\n\nLet's evaluate the peak systemic burden at each administration time:\n- At $t = 0^+$: $A(0^+) = A_{0,1} = 9$ mg. This is well below the $280$ mg cap.\n\n- At $t = 15^+$:\n$$A(15^+) = 9 \\exp(-15k) + y$$\nThe constraint is $9 \\exp(-15k) + y \\le 280$. This sets an upper bound on $y$:\n$$y \\le 280 - 9 \\exp(-15k)$$\n\n- At $t = 60^+$:\n$$A(60^+) = 9 \\exp(-60k) + y \\exp(-k(60 - 15)) + 6 = 9 \\exp(-60k) + y \\exp(-45k) + 6$$\nThe constraint is $9 \\exp(-60k) + y \\exp(-45k) + 6 \\le 280$, which implies:\n$$y \\le \\frac{274 - 9 \\exp(-60k)}{\\exp(-45k)}$$\n\n- At $t = 75^+$:\n$$A(75^+) = 9 \\exp(-75k) + y \\exp(-k(75 - 15)) + 6 \\exp(-k(75 - 60)) + y$$\n$$A(75^+) = 9 \\exp(-75k) + y \\exp(-60k) + 6 \\exp(-15k) + y$$\n$$A(75^+) = (9 \\exp(-75k) + 6 \\exp(-15k)) + y(1 + \\exp(-60k))$$\nThe constraint is $(9 \\exp(-75k) + 6 \\exp(-15k)) + y(1 + \\exp(-60k)) \\le 280$, which implies:\n$$y \\le \\frac{280 - 9 \\exp(-75k) - 6 \\exp(-15k)}{1 + \\exp(-60k)}$$\n\nTo find the maximum allowable value of $y$, we must find the most restrictive of these three inequalities. This requires calculating the values of the exponential terms using $k = \\frac{\\ln(2)}{100}$.\n\n$\\exp(-15k) = \\exp(-15 \\frac{\\ln(2)}{100}) = \\exp(-0.15 \\ln(2)) = 2^{-0.15} \\approx 0.901355$\n$\\exp(-45k) = \\exp(-45 \\frac{\\ln(2)}{100}) = \\exp(-0.45 \\ln(2)) = 2^{-0.45} \\approx 0.732043$\n$\\exp(-60k) = \\exp(-60 \\frac{\\ln(2)}{100}) = \\exp(-0.60 \\ln(2)) = 2^{-0.60} \\approx 0.660350$\n$\\exp(-75k) = \\exp(-75 \\frac{\\ln(2)}{100}) = \\exp(-0.75 \\ln(2)) = 2^{-0.75} \\approx 0.594604$\n\nNow we compute the upper limit for $y$ from each inequality:\n1.  From the peak at $t = 15^+$:\n    $y \\le 280 - 9 \\times (0.901355) = 280 - 8.112195 = 271.887805$\n\n2.  From the peak at $t = 60^+$:\n    $y \\le \\frac{274 - 9 \\times (0.660350)}{0.732043} = \\frac{274 - 5.94315}{0.732043} = \\frac{268.05685}{0.732043} \\approx 366.179$\n\n3.  From the peak at $t = 75^+$:\n    $y \\le \\frac{280 - 9 \\times (0.594604) - 6 \\times (0.901355)}{1 + 0.660350} = \\frac{280 - 5.351436 - 5.40813}{1.660350} = \\frac{269.240434}{1.660350} \\approx 162.158$\n\nThe value of $y$ must satisfy all three inequalities simultaneously. Therefore, $y$ must be less than or equal to the minimum of these three upper bounds:\n$$y_{\\max} = \\min(271.887805, 366.179, 162.158) = 162.158 \\, \\text{mg}$$\nThe most restrictive condition arises from the peak systemic burden at $t=75$ minutes, the time of the final dose.\n\nThe problem asks for the result to be rounded to three significant figures.\n$$y_{\\max} \\approx 162 \\, \\text{mg}$$\nThus, the maximum allowable per-injection infiltration dose is $162$ mg.", "answer": "$$\\boxed{162}$$", "id": "4768902"}]}